Chinese investments to be aimed at developing genetic research in Uzbekistan
Tashkent, Uzbekistan (UzDaily.com) -- At the Ministry of Higher Education, Science and Innovation, Deputy Shakhlo Turdikulova met with a delegation led by the Executive President for Global Development of the Beijing Genomics Institute (BGI), Dr. Ning Li.
During the meeting, issues of attracting investments to Uzbekistan for the development of genomic and biotechnological research were discussed. In particular, an agreement was reached on the transfer of technologies for the introduction of a genetic passport and screening for carriers of genetic diseases, and ways of implementing a project to create a National Biobank in the republic were outlined.
The Chinese side highly appreciated the pilot project of the joint company "Genscreen" being implemented in the country to screen newborns for 48 metabolic diseases, and outlined ways to expand the range of genetic studies for the population of the republic.
The leading scientific and medical company in Asia and the world - Beijing Genomics Institute was founded in 1999 to participate in the project of decoding the Human Genome from China. Over 23 years, BGI Group has grown into a large corporation that brings together commercial and non-profit companies whose activities are based on scientific research and focus on life sciences, genomics, agriculture, as well as discoveries and solutions leading to early detection and treatment of diseases , improving the lives of people in various countries and regions of the world.